Search

Search Constraints

You searched for: Author/Creator Dirven, Clemens M F

Search Results

2. DDDR-27. A PATIENT-DERIVED DRUG SCREENING PLATFORM PREDICTS RESPONSE TO TEMOZOLOMIDE AND IDENTIFIES POTENTIAL NEW TREATMENTS FOR GLIOBLASTOMA. (14th November 2022)

3. Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology. Issue 7 (July 2015)

4. Differences in spatial distribution between WHO 2016 low-grade glioma molecular subgroups. Issue 1 (31st May 2019)

5. Differences in spatial distribution between WHO 2016 low-grade glioma molecular subgroups. Issue 1 (31st May 2019)

6. Effect of awake craniotomy in glioblastoma in eloquent areas (GLIOMAP): a propensity score-matched analysis of an international, multicentre, cohort study. Issue 6 (June 2022)

7. EXTH-15. DRUG SCREENING ON PATIENT GBM CELL CULTURES IDENTIFIES OMACETAXINE MEPESUCCINATE AS A POTENT ANTI-GLIOMA AGENT WITH THE ABILITY TO CROSS THE BLOOD-BRAIN-BARRIER. (14th November 2022)

8. EXTH-54. CO-CULTURE OF PATIENT-DERIVED GLIOBLASTOMA CELL LINES WITH AUTOLOGOUS PBMCS FOR THE INVESTIGATION OF ONCOLYTIC VIRUS RESPONSE. (14th November 2022)

9. Generation, characterization, and drug sensitivities of 12 patient-derived IDH1-mutant glioma cell cultures. Issue 1 (2nd August 2021)

10. Monocytes carrying GFAP detect glioma, brain metastasis and ischaemic stroke, and predict glioblastoma survival. Issue 1 (26th December 2020)